Abstract: The present invention suggests the use of independent, wireless, smart and therefore self-contained sensors (3, 4, 5) in a patient monitoring system (1). The sensors (3, 4, 5) provide their own communication system for transmitting acquired signals to a patient monitor (8) etc. Furthermore a patient identifier (26) is associated to the communication. This approach introduces a patient-related concept, where all communication is personalized and assigned to the patient (2).
Type:
Grant
Filed:
June 3, 2005
Date of Patent:
February 2, 2016
Assignee:
KONINKLIJKE PHILIPS N.V.
Inventors:
Harald Greiner, Bernd Wilm, Kai Hassing, Winfried Kaiser
Abstract: A glucose sensor suitable for measuring glucose levels in human saliva is provided. Systems containing the glucose sensor and methods for making and using the sensor are also provided. The glucose sensor is highly sensitive and can detect glucose levels at least down to 5 ppm. Fabrication of the sensor involves depositing single-walled carbon nanotubes onto the surface of a working electrode in a 3 electrode electrochemical detector and functionalizing the nanotubes by depositing layers of polymers, metallic nanoparticles, and glucose oxidase enzyme onto the nanotubes. The sensor can be used as a disposable, single-use device or as part of an analytical system, such as a microfluidics system, for the analysis of multiple analytes. The sensor enables the diagnosis and monitoring of diabetes to be performed without pain or the need for finger pricks in a home or clinical setting.
Abstract: Described herein is a lapel adaptor for use with a physiologic sensor pod having a housing including a top surface, a bottom surface, a peripheral surface, a groove extending around the peripheral surface, and a pair of electrodes spaced apart from one another on the bottom surface. The lapel adaptor includes a first portion comprising an elastic ring including an opening having an inner circumference slightly smaller than an outer circumference of the groove extending around the peripheral surface of the sensor pod housing. The lapel adaptor also includes a second portion having a pair of magnets spaced apart from one another by substantially a same distance as a distance between the pair of electrodes on the bottom surface of the sensor pod housing. The lapel adaptor further includes a third portion that enables the first and second portions of the lapel adaptor to be folded toward one another.
Abstract: Verification of patient sample electrolyte results using a separate quantitative measurement of sample resistivity. Sample resistivity may be used to measure small differences in resistivity of one sample to the next, and in comparison to a standard solution, in order to verify the results of sample electrolyte measurements being measured at the same time by, for example, individual ion selective electrodes (ISE) in a clinical analyzer. Providing a separate or secondary quantitative means for verification of the measured results of sample electrolytes using sample resistivity solves the problem of electrolyte result variability in sample electrolyte measurements. The process may compare a measured sample resistivity to an expected resistivity value as a verification of the accuracy of individual electrolyte results. Suspect samples—e.g., where the electrolyte resistivity results do not fit the expected resistivity—may be flagged.
Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
Type:
Grant
Filed:
January 30, 2014
Date of Patent:
November 3, 2015
Assignee:
DexCom, Inc.
Inventors:
Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
Abstract: A calibration system is disclosed for calibrating a first physiological monitoring device using a second physiological monitoring device. The first physiological monitor measures a first indication of a physiological parameter. The second physiological monitor measures a second indication of the physiological parameter. The first and second indications are used to calibrate the first physiological monitoring device.
Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
Type:
Grant
Filed:
January 30, 2014
Date of Patent:
November 3, 2015
Assignee:
DexCom, Inc.
Inventors:
Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
Abstract: The invention relates to a method and arrangement for continuously measuring substances in a pressurised body fluid. A probe (202) for enabling continuous measurement of the concentration of one or more substances in a pressurized body fluid is provided. The probe is adapted to be inserted into the pressurized body fluid, and comprises an interface and an outlet lumen. Furthermore, the probe is configured so that a continuous and spontaneous fluid flow is established from the body fluid through the interface to the outlet lumen. The fluid flow from the outlet may be analyzed by a sensor.
Type:
Grant
Filed:
November 16, 2010
Date of Patent:
October 27, 2015
Assignee:
Maquet Critical Care AB
Inventors:
Anton Karlsson, Henrik Falkén, Gabriel Österdahl, Jan Liska
Abstract: Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.
Type:
Grant
Filed:
June 13, 2012
Date of Patent:
October 6, 2015
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Michael Robert Mensinger, Ying Li, Aarthi Mahalingam, John Michael Dobbles
Abstract: Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.
Type:
Grant
Filed:
June 13, 2012
Date of Patent:
October 6, 2015
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Michael Robert Mensinger, Ying Li, Aarthi Mahalingam, John Michael Dobbles
Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.
Type:
Grant
Filed:
February 20, 2009
Date of Patent:
September 22, 2015
Assignee:
DexCom, Inc.
Inventors:
Michael Robert Mensinger, John Michael Dobbles, Apurv U. Kamath, Beat Stadelmann, Deborah M. Ruppert, Nassar Salamanti, Richard C. Yang
Abstract: A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining whether there is a change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is a decrease in the pacing threshold during delivery of the adjusted pacing therapy, and determine hyperkalemia in response to the decrease in the pacing threshold during delivery of the adjusted pacing therapy being present.
Type:
Grant
Filed:
October 17, 2013
Date of Patent:
September 15, 2015
Assignee:
Medtronic, Inc.
Inventors:
Amy E. Thompson-Nauman, Michael J Ebert, Rick D McVenes, Nathan A Grenz
Abstract: The present invention provides an electrochemical sensor that employs multiple electrode areas that are exposed for contact with a body fluid, e.g., when the sensor is inserted subcutaneously into a patient's skin. The exposed electrode areas are arranged symmetrically, such that a symmetrical potential distribution is produced when an AC signal is applied to the sensor. The sensors in accordance with these teachings can advantageously be used with AC signals to determine characteristics of the sensor and thus improve sensor performance. These teachings also provide a biocompatible sensor with multiple reference electrode areas that are exposed for contact with body fluid.
Abstract: A sensor unit for use in measurements on a subject is presented. The sensor unit includes a near field electromagnetic sensor and a flexible signal transmission structure, which are integral with one another by means of at least one common continuous surface. The flexible signal transmission structure is constructed from a first layer including signal connection lines associated with sensor cells near field electromagnetic sensor and a second electrically conductive layer electrically coupled to the electrically conductive material of the sensor.
Type:
Grant
Filed:
August 3, 2010
Date of Patent:
June 30, 2015
Assignee:
DUNE MEDICAL DEVICES LTD.
Inventors:
Gil Cohen, Dan Hashimshony, Iddo Geltner, Harel Golombek
Abstract: A composite sensor for detecting angular velocity and acceleration includes an angular velocity detecting element, an acceleration detecting element, an angular velocity signal processing IC, an acceleration signal processing IC, and a housing. The housing is formed of a multilayered circuit board and accommodates the angular velocity detecting element, the acceleration detecting element, the angular velocity signal processing IC, and the acceleration signal processing IC. The housing connects the angular velocity detecting element electrically to the angular velocity signal processing IC, and also connects the acceleration detecting element electrically to the acceleration signal processing IC.
Abstract: An analyte monitor including a sensor, a sensor control unit, and a display unit is disclosed. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
Type:
Application
Filed:
January 6, 2015
Publication date:
May 28, 2015
Inventors:
Peter C. Simpson, Mark C. Brister, Matthew D. Wightlin
Abstract: The present application provides Ag/AgCl based reference electrodes having an extended lifetime that are suitable for use in long term amperometric sensors. Electrochemical sensors equipped with reference electrodes described herein demonstrate considerable stability and extended lifetime in a variety of conditions.
Type:
Grant
Filed:
August 27, 2012
Date of Patent:
May 26, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
Zenghe Liu, Benjamin J. Feldman, Brian Cho, Udo Hoss
Abstract: An integrated passive wireless chip diagnostic sensor system is described that can be interrogated remotely with a wireless device such as a modified cell phone incorporating multi-protocol RFID reader capabilities (such as the emerging Gen-2 standard) or Bluetooth, providing universal easy to use, low cost and immediate quantitative analyses, geolocation and sensor networking capabilities to users of the technology. The present invention can be integrated into various diagnostic platforms and is applicable for use with low power sensors such as thin films, MEMS, electrochemical, thermal, resistive, nano or microfluidic sensor technologies.
Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
Type:
Grant
Filed:
March 2, 2007
Date of Patent:
May 26, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Fredric C. Colman
Abstract: Generally, embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have improved signal response and stability by inclusion of a coating including a hydrogel, a crosslinker, and a swelling modulator, where the coating is disposed proximate to a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
Type:
Grant
Filed:
November 24, 2009
Date of Patent:
May 26, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
Balasubrahmanya S. Bommakanti, Gary Sandhu, Udo Hoss
Abstract: An electrochemical test sensor for detecting the concentration of an analyte in a fluid sample. The electrochemical test sensor includes a housing that has a first end and a second opposing end. The housing includes an opening at the first end to receive a fluid test sample. An electrode assembly includes a substrate, a working electrode, a counter electrode and a reagent. The substrate has a first surface and an opposing second surface. The working electrode is disposed on the first surface of the substrate, and the counter electrode is disposed on the second surface of the substrate. The electrode assembly is positioned within the housing to define a reaction channel. The electrochemical test sensor may be used with a removable lancet mechanism or integrated within a lancet mechanism to form one integral unit.
Abstract: Methods and systems for monitoring a well-being of a target are disclosed. In a method embodiment, data representing a process electric potential signal is received by a computer system. The process electric potential signal may be generated at least in part by one or more electric potential sensors in response to the detection of a change in an electric field of a target spaced apart from the one or more electric potential sensors. The method may further include identifying, using the computer system and based at least in part on the data electronically received by the computer system, a recurring pattern in the received data. The method may also include determining, using the computer system and based at least in part on the received data, whether a deviation from the recurring pattern transgresses a threshold. The deviation may comprise a subset of the data electronically received by the computer system.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
May 19, 2015
Assignee:
LIFE DETECTION SYSTEMS, INC.
Inventors:
Eric Howie, Guy McIlroy, John Haggis, Nanci Yuan
Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Type:
Grant
Filed:
January 17, 2013
Date of Patent:
May 19, 2015
Assignee:
DEXCOM, INC.
Inventors:
Peter C. Simpson, Mark Brister, Jacob S. Leach
Abstract: Correction for initial variation in thickness of a polymer layer and for changes in the coating thickness that occur after implantation of a biosensor and therefore provides substantial increase in the accuracy and lifetime of implantable sensors is done using a factor derived from the decay of potential.
Abstract: One or more therapeutic fluids, such as for example insulin can be delivered to a body. In addition or alternatively, the concentrations of one or more analytes can be measured in vivo. A feedback process can be used to regulate levels of the one or more analytes based on the measurements via delivery of the one or more therapeutic fluids. Related systems, apparatus, methods, and/or articles are also described.
Type:
Grant
Filed:
December 21, 2007
Date of Patent:
May 12, 2015
Assignee:
Roche Diagnostics Operations, Inc.
Inventors:
Ofer Yodfat, Gavriel J. Iddan, Ruthy Kaidar, Gali Shapira
Abstract: Methods, structures, devices and systems are disclosed for fabricating and implementing electrochemical biosensors and chemical sensors. In one aspect, a method of producing an epidermal biosensor includes forming an electrode pattern onto a coated surface of a paper-based substrate to form an electrochemical sensor, the electrode pattern including an electrically conductive material and an electrically insulative material configured in a particular design layout, and attaching an adhesive sheet on a surface of the electrochemical sensor having the electrode pattern, the adhesive sheet capable of adhering to skin or a wearable item, in which the electrochemical sensor, when attached to the skin or the wearable item, is operable to detect chemical analytes within an external environment.
Type:
Application
Filed:
May 10, 2013
Publication date:
May 7, 2015
Inventors:
Joseph Wang, Joshua Ray Windmiller, Amay Jairaj Bandodkar
Abstract: Wearable apparatus for monitoring various physiological and environmental factors are provided. Real-time, noninvasive health and environmental monitors include a plurality of compact sensors integrated within small, low-profile devices, such as earpiece modules. Physiological and environmental data is collected and wirelessly transmitted into a wireless network, where the data is stored and/or processed.
Type:
Application
Filed:
January 8, 2015
Publication date:
May 7, 2015
Inventors:
Steven Francis LeBoeuf, Jesse Berkley Tucker, Michael Edward Aumer
Abstract: Novel membranes comprising various polymers containing heterocyclic nitrogen groups are described. These membranes are usefully employed in electrochemical sensors, such as amperometric biosensors. More particularly, these membranes effectively regulate a flux of analyte to a measurement electrode in an electrochemical sensor, thereby improving the functioning of the electrochemical sensor over a significant range of analyte concentrations. Electrochemical sensors equipped with such membranes are also described.
Abstract: A method and an apparatus for measuring glucose level in the body fluid of a subject, typically blood glucose level, by measuring impedance of a body tissue, with two pairs of electrodes, two electrodes for injecting current into a body tissue and two electrodes for detecting the ensuing voltage of the body tissue. The body tissue is typically a sub-dermal or sub-cutaneous tissue. The measured impedance of the body tissue is used to correlate with directly determined glucose levels to determine the glucose level from the measured impedance. It is thus possible to determine body fluid glucose levels in a reliable and reproducible manner.
Type:
Grant
Filed:
February 4, 2005
Date of Patent:
May 5, 2015
Assignee:
Dermal Devices, Inc.
Inventors:
Stig Ollmar, Peter Aberg, Ulrik Birgersson, Fredrik Neiderud
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
Type:
Application
Filed:
December 18, 2014
Publication date:
April 30, 2015
Inventors:
Mark C. Brister, Jack Pryor, John Nolting, Jacob S. Leach, Luis Pestana, Nelson Quintana, Vance Swanson, Paul V. Goode, JR., James Patrick Thrower
Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.
Type:
Grant
Filed:
September 10, 2010
Date of Patent:
April 28, 2015
Assignee:
DexCom, Inc.
Inventors:
Michael Robert Mensinger, John Michael Dobbles, Apurv U. Kamath, Beat Stadelmann, Deborah M. Ruppert, Nasser Salamati, Richard C. Yang
Abstract: In aspects of the present disclosure, an auto turn on blood glucose monitoring unit including a calibration unit integrated with one or more components of an analyte monitoring system is provided. Also disclosed are methods, systems, devices and kits for providing the same.
Type:
Grant
Filed:
June 17, 2013
Date of Patent:
April 28, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
Adam Heller, Benjamin Jay Feldman, Shridhara Alva Karinka, Yi Wang, John R. Galasso
Abstract: A body-mountable pyruvate sensing device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode, a reference electrode, and a reagent localized near the working electrode that selectively reacts with pyruvate. Application of a voltage between the working electrode and the reference electrode causes a current related to a concentration of pyruvate in a fluid to which the electrochemical sensor is exposed; the current is measured by the body-mountable device and wirelessly communicated.
Abstract: An implantable biocompatible biosensor is described herein. The biosensor includes a chip layer including a plurality of holes fabricated vertically there through, a power source, one or more sensors on the chip layer and coupled to the power source and a hydrogel matrix including one or more angiogenesis stimulating factors in contact with the chip layer. The stimulating factors stimulate growth of organic material through the plurality of holes when the biosensor is implanted in a subject.
Type:
Grant
Filed:
July 9, 2013
Date of Patent:
April 21, 2015
Assignee:
California Institute of Technology
Inventors:
Akram Sarwat Sadek, Axel Scherer, Muhammad Mujeeb-U-Rahman
Abstract: Wireless molecular sensor methods and systems integrate radio frequency (RF) technology to interrogate, power, operate and/or readout signals corresponding to levels of molecules of interest from microelectromechanical systems (MEMS) implanted within the body. Various alternative embodiments are disclosed.
Type:
Grant
Filed:
May 11, 2011
Date of Patent:
April 21, 2015
Assignee:
VeriTeQ Acquisition Corporation
Inventors:
Randolph K. Geissler, Scott Nelson, Steve Lewis
Abstract: An apparatus, systems, and methods related to determining an identity and a concentration of an intravenous fluid. The apparatus, the systems, and the methods described herein may provide near real-time monitoring and/or determination of an identity of components of the intravenous fluid. A concentration and the identity of all of the components of the intravenous fluid may be identified simultaneously.
Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
Type:
Grant
Filed:
March 7, 2007
Date of Patent:
April 21, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Fredric C. Colman
Abstract: The present invention provides methods of notifying a user of a smartphone event through use of an energizable ophthalmic lens. In some embodiments, the smartphone may be paired with a specified ophthalmic lens, wherein the pairing may limit wireless communication to communication between the two specified devices. The smartphone may transmit smartphone event data, which may activate an indicator in the ophthalmic lens. In some embodiments, the user may respond to the notification of the smartphone event. The response may trigger an internal action within the ophthalmic lens, or the response may be transmitted to the smartphone, triggering an action in the smartphone. The present invention further describes a method of using an ophthalmic lens with a smartphone event indicator, including methods of pairing an ophthalmic lens with the specified smartphone.
Type:
Grant
Filed:
July 11, 2013
Date of Patent:
April 21, 2015
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Randall Braxton Pugh, Camille A. Higham
Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
Type:
Grant
Filed:
October 30, 2007
Date of Patent:
April 21, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
Adam Heller, Steven H. Drucker, Robert Y. Jin, Jeffery V. Funderburk
Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
Type:
Grant
Filed:
December 29, 2004
Date of Patent:
April 21, 2015
Assignee:
Abbott Diabetes Care Inc.
Inventors:
James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
Abstract: A mountable device includes a bio-compatible structure embedded in a polymer that defines at least one mounting surface. The bio-compatible structure includes an electronic component having electrical contacts, sensor electrodes, and electrical interconnects between the sensor electrodes and the electrical contacts. The bio-compatible structure is fabricated such that it is fully encapsulated by a bio-compatible material, except for the sensor electrodes. In the fabrication, the electronic component is positioned on a first layer of bio-compatible material and a second layer of bio-compatible material is formed over the first layer of bio-compatible material and the electronic component. The electrical contacts are exposed by removing a portion of the second layer, a conductive pattern is formed to define the sensor electrodes and electrical interconnects, and a third layer of bio-compatible material is formed over the conductive pattern.
Abstract: A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.
Type:
Grant
Filed:
March 14, 2014
Date of Patent:
April 14, 2015
Assignee:
Sano Intelligence, Inc.
Inventors:
Ashwin Pushpala, Alan Szmodis, Matthew Chapman, Weldon Hall, Scott Miller, Hooman Hafezi
Abstract: Embodiments of the invention provide analyte sensors and sensor systems such as amperometric glucose sensors used in the management of diabetes as well as optimized methods for monitoring analytes using such sensors and sensor systems.
Type:
Grant
Filed:
May 6, 2011
Date of Patent:
April 14, 2015
Assignee:
Medtronic MiniMed, Inc.
Inventors:
Jefferson Rose, Ashwin K. Rao, Ning Yang, Chia-Hung Chiu, Ying Luo, Rebecca K. Gottlieb
Abstract: Sensor elements are provided for determining at least one analyte concentration in a body fluid. The sensor elements are at least partially implantable into a body tissue and have a substrate and at least two electrodes. One electrode is a working electrode having at least one conductive pad applied to the substrate and at least one electrically conductive sensor material is applied to the conductive pad that includes at least one detector substance adapted to perform an electrically detectable electrochemical detection reaction with the analyte. Another electrode is a counter electrode having at least one counter electrode conductive pad applied to the substrate. The sensor elements also include at least one electrically insulating material that surrounds at least the counter electrode on all sides, where a height of the electrically insulating material at least equals a height of the counter electrode conductive pad.
Type:
Application
Filed:
December 10, 2014
Publication date:
April 9, 2015
Inventors:
Sabine Achmann, Holger Kotzan, Ulrich Mueller, Monika Strasser, Herbert Wieder
Abstract: A calibration system is disclosed for calibrating a first physiological monitoring device using a second physiological monitoring device. The first physiological monitor measures a first indication of a physiological parameter. The second physiological monitor measures a second indication of the physiological parameter. The first and second indications are used to calibrate the first physiological monitoring device.
Abstract: In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.
Type:
Application
Filed:
December 5, 2014
Publication date:
April 2, 2015
Applicant:
Abbott Diabetes Care Inc.
Inventors:
Adam Heller, Benjamin Jay Feldman, Shridhara Alva Karinka, Yi Wang, John R. Galasso
Abstract: The invention provides a device for contacting a surface of a tissue within a patient's body to determine a physiologic parameter of the patient. The device typically comprises a sensor responsive to the physiologic parameter and a probe housing the sensor. The probe is constructed to allow the sensor to be secured at a sensing area adjacent to a surface of a patient's tissue, without need for an adhesive and without disturbing the blood flow within the measurement region of the tissue. The device may also include a means for reducing interference in the sensing area. Preferably, the device further comprises an indicating means operably connected to the sensor for indicating an analyte quantity and/or concentration associated with the physiologic parameter. The invention also provides a method for determining a physiologic parameter of a patient.
Type:
Grant
Filed:
February 14, 2003
Date of Patent:
March 31, 2015
Assignee:
Exostat Medical, Inc.
Inventors:
Edward J. Anderson, Brandon W. Reynolds, Kent R. Winger, Victor E. Kimball